HJLI Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 okt 2021 @ 06:00):

Stats
Dagens volum	221 867
Gjennomsnittsvolum	777 480
Markedsverdi	98.32M
EPS	$-0.280 ( 2021-08-11 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.491 (4.73%)

Insider Trading

Date	Person	Action	Amount	type
2021-05-18	Berman Robert Andrew	Buy	3 000	Common Stock, $0.00001 par value
2020-07-18	Duhay Francis	Buy	62 500	Common Stock
2020-07-18	Duhay Francis	Buy	100 000	Stock Option
2019-06-07	Biodyne Holding, S.a.	Sell	684 813	Common Stock

INSIDER POWER
0.00
Last 4 transactions
Buy: 165 500 \| Sell: 684 813

Volum Korrelasjon

Lang: 0.03 (neutral)

Kort: 0.15 (neutral)

Signal:(69.18) Neutral

Hancock Jaffe Korrelasjon

10 Mest positive korrelasjoner
SPRT	0.906
XOG	0.893
PAIC	0.886
TLGT	0.884
CYN	0.881
ICAD	0.874
LSAK	0.873
RAPT	0.868
SVAC	0.866
AMD	0.864

10 Mest negative korrelasjoner
ARDS	-0.91
IBRX	-0.895
VINC	-0.888
NETE	-0.883
HRMY	-0.878
ALRS	-0.87
TCBIO	-0.865
RPTX	-0.859
BOTZ	-0.856
VIEW	-0.853

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Hancock Jaffe Korrelasjon - Valuta/Råvare

0.29
( neutral )

0.71
( moderate )

-0.10
( neutral )

0.12
( neutral )

0.47
( neutral )

-0.75
( moderate negative )

Hancock Jaffe Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2023
Omsetning:	$0
Bruttogevinst:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2022
Omsetning:	$0
Bruttogevinst:	$-525 000 (0.00 %)
EPS:	$-2.16

FY	2020
Omsetning:	$4 252.00
Bruttogevinst:	$4 252.25 (100.00 %)
EPS:	$-0.0106

Financial Reports:

No articles found.

Hancock Jaffe

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.